AUG 02, 2022 8:54 AM PDT

CRISPR Technology Breaks New Ground with Edits to Gene that Regulates Cholesterol

WRITTEN BY: Zoe Michaud

In 2013, scientists described a method for editing the genome of eukaryotic cells (such as those found in humans) using CRISPR technology. Since then, the CRISPR method has been researched extensively, but its use in humans has been limited to exploratory trials for the purpose of treating rare diseases. 

CRISPR was also used in 2021 to treat a handful of patients with Sickle Cell Disease. Results of the study were tentavively positive, though the researchers noted the study size and length of follow-up data as limitations in gauging success of the method in treating genetic diseases. 

Biotechnology company Verve Therapeutics is currently investigating CRISPR-like gene editing to edit a human gene, PCSK9, that regulates cholesterol. This is a significant leap in this field, since it is investigating a gene edit that affects a much more substantial portion of the human population than previous studies on rare genetic disease.

PCSK9 encodes a protein that helps regulate the amount of cholesterol in the bloodstream. By converting a single base of the PCSK9 gene in people with a condition called heterozygous familial hypercholesterolaemia, the researchers expect to significantly reduce levels of cholesterol and subsequent risk of heart disease in these patients. 

Verve Therapeutics has previously conducted preclinical studies to validate the efficacy of their gene editing approach in reducing cholesterol. They hope that targeting DNA in the liver in humans will be able to impart lifelong changes to expressed genes and lower the risk of cardiovascular disease. 

The company has now launched a clinical trial in which a human participant in New Zealand underwent gene editing. The patient enrolled in the trial has heterozygous familial hypercholesterolaemia and is suffering from heart disease as a result. The trial is planned to involve 40 participants in total. 

Though this participant was actively experiencing heart disease at the time the trial began, scientists at Verve Therapeutics hope that the technology could be applied in a preventative manner so that gene edits are made before cardiovascular disease manifests. 

Sekar Kathiresan, CEO of Verve Therapeutics, says that “if this works and is safe, this is the answer to heart attack—this is the cure.” 

Sources: Science, The New England Journal of Medicine, Nature, Verve Therapeutics

About the Author
Biology
Zoe (she/her) is a science writer and a scientist working in genomics. She received her B.S. from the University of Connecticut with a focus in Evolutionary Biology. At Labroots, she focuses on writing scientific content related to clinical research and diagnostics.
You May Also Like
JUL 28, 2022
Clinical & Molecular DX
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
JUL 28, 2022
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
Pancreatic cancer typically does not cause symptoms until after it has spread to other organs. This makes it very diffic ...
AUG 23, 2022
Microbiology
Explaining the Alarming Rise of Superbugs During the Pandemic
AUG 23, 2022
Explaining the Alarming Rise of Superbugs During the Pandemic
With effort, we all can help counter the rise of bacterial pathogens that resist the effects of multiple antibiotics.
AUG 27, 2022
Health & Medicine
It's Not the Amount of Exercise That Counts; It's How Often You Do It
AUG 27, 2022
It's Not the Amount of Exercise That Counts; It's How Often You Do It
Is it better to exercise more frequently or for longer but less often? That is the question. But, of course, it all depe ...
AUG 30, 2022
Cardiology
Loneliness Increases Death Risk from Heart Attack and Stroke
AUG 30, 2022
Loneliness Increases Death Risk from Heart Attack and Stroke
Loneliness and social isolation are associated with worse heart and brain health.
SEP 20, 2022
Clinical & Molecular DX
The Health of Your Teeth Could Impact Your Heart: Here's How
SEP 20, 2022
The Health of Your Teeth Could Impact Your Heart: Here's How
A variety of past studies have shown that there is some connection between oral health and heart health. Gum disease is ...
SEP 30, 2022
Health & Medicine
Financial Incentive Influences Decision to Help for Less Empathic Individuals
SEP 30, 2022
Financial Incentive Influences Decision to Help for Less Empathic Individuals
A highly empathic person tends to help a person in need willingly, but what about those individuals with low empathy? A ...
Loading Comments...